Literature DB >> 10490432

Jaundice with hypertrophic pyloric stenosis as an early manifestation of Gilbert syndrome.

P Trioche1, J Chalas, J Francoual, L Capel, A Lindenbaum, M Odièvre, P Labrune.   

Abstract

Jaundice associated with hypertrophic pyloric stenosis was recognised in three patients; previous reports have suggested that this is a possible early manifestation of Gilbert syndrome. Most patients with Gilbert syndrome are homozygous for a (TA)(7)TAA polymorphism in the gene promoter coding for bilirubin glucuronosyltransferase. Two of the reported patients were homozygous for the (TA)(7)TAA polymorphism whereas the third was heterozygous for the same polymorphism. Furthermore, no other factors contributing to jaundice in the three patients were found. These results suggest that jaundice associated with hypertrophic pyloric stenosis is due to molecular defects within the gene promoter.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10490432      PMCID: PMC1718098          DOI: 10.1136/adc.81.4.301

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  13 in total

1.  Gilbert's syndrome is a contributory factor in prolonged unconjugated hyperbilirubinemia of the newborn.

Authors:  G Monaghan; A McLellan; A McGeehan; S Li Volti; F Mollica; I Salemi; Z Din; A Cassidy; R Hume; B Burchell
Journal:  J Pediatr       Date:  1999-04       Impact factor: 4.406

2.  UGT1 promoter polymorphism accounts for increased neonatal appearance of hereditary spherocytosis.

Authors:  A Iolascon; M F Faienza; A Moretti; S Perrotta; E Miraglia del Giudice
Journal:  Blood       Date:  1998-02-01       Impact factor: 22.113

3.  Gilbert syndrome accelerates development of neonatal jaundice.

Authors:  J D Bancroft; B Kreamer; G R Gourley
Journal:  J Pediatr       Date:  1998-04       Impact factor: 4.406

4.  Jaundice with hypertrophic pyloric stenosis: a possible early manifestation of Gilbert syndrome.

Authors:  P Labrune; A Myara; P Huguet; F Trivin; M Odievre
Journal:  J Pediatr       Date:  1989-07       Impact factor: 4.406

5.  Sequence of exons and the flanking regions of human bilirubin-UDP-glucuronosyltransferase gene complex and identification of a genetic mutation in a patient with Crigler-Najjar syndrome, type I.

Authors:  P J Bosma; N R Chowdhury; B G Goldhoorn; M H Hofker; R P Oude Elferink; P L Jansen; J R Chowdhury
Journal:  Hepatology       Date:  1992-05       Impact factor: 17.425

6.  Genetic defects of the UDP-glucuronosyltransferase-1 (UGT1) gene that cause familial non-haemolytic unconjugated hyperbilirubinaemias.

Authors:  D J Clarke; N Moghrabi; G Monaghan; A Cassidy; M Boxer; R Hume; B Burchell
Journal:  Clin Chim Acta       Date:  1997-10-09       Impact factor: 3.786

7.  Genetic variation in bilirubin UPD-glucuronosyltransferase gene promoter and Gilbert's syndrome.

Authors:  G Monaghan; M Ryan; R Seddon; R Hume; B Burchell
Journal:  Lancet       Date:  1996-03-02       Impact factor: 79.321

8.  Contribution of two missense mutations (G71R and Y486D) of the bilirubin UDP glycosyltransferase (UGT1A1) gene to phenotypes of Gilbert's syndrome and Crigler-Najjar syndrome type II.

Authors:  K Yamamoto; H Sato; Y Fujiyama; Y Doida; T Bamba
Journal:  Biochim Biophys Acta       Date:  1998-04-28

9.  Pyloric stenosis presenting as severe prolonged jaundice. A case report.

Authors:  M M Lippert
Journal:  S Afr Med J       Date:  1986-03-29

10.  The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome.

Authors:  P J Bosma; J R Chowdhury; C Bakker; S Gantla; A de Boer; B A Oostra; D Lindhout; G N Tytgat; P L Jansen; R P Oude Elferink
Journal:  N Engl J Med       Date:  1995-11-02       Impact factor: 91.245

View more
  1 in total

Review 1.  Pyloric stenosis: an enigma more than a century after the first successful treatment.

Authors:  Yousef El-Gohary; Abdelhafeez Abdelhafeez; Elizabeth Paton; Ankush Gosain; Andrew J Murphy
Journal:  Pediatr Surg Int       Date:  2017-10-13       Impact factor: 1.827

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.